Development of an immunoassay specific for the PSA-ACT complex without the problem of high background

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 1, 1998, Pages 14-19

  Wu, James T ^a,b   Zhang, Ping ^a   Liu, Grace H ^a   Wilson, Lori ^a  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Anti PSA antibody; Antichymotrypsin; Free PSA; PAGE; Prostate cancer; Protease activity; Protease inhibitor; PSA complexes; Total PSA

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; CASEIN; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROTEINASE; PROTEINASE INHIBITOR;

ACCURACY; ANTIBODY DETECTION; ARTICLE; CANCER SCREENING; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; PROSTATE CARCINOMA;

ALPHA 1-ANTICHYMOTRYPSIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PROSTATE-SPECIFIC ANTIGEN;

EID: 0031889710     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:1<14::AID-JCLA3>3.0.CO;2-J     Document Type: Article

References (15)

1. Wu JT: Assay for prostate specific antigen (PSA): Current problems and possible solutions. J Clin Lab Anal 8:51-62, 1994.
2. Wu JT: Serum prostate specific antigen assay - An update. Western J Med (Epitomes-Pathology) 162:447-448, 1995.
3. Catalona WJ, Smith DS, Ratliff T, et al.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156-1161, 1991.
4. Chan DW, Bruzek DJ, Oestlering JE, et al.: Prostate-specific antigen as a marker for prostate cancer: A monoclonal and a polyclonal immunoassay compared. Clin Chem 3:1916-1920, 1987.
5. Horton GL, Bahnson RR, Daft M, et al.: Differences in values obtained with 2 assays of prostate specific antigen. J Urol 139:762, 1988.
6. Graves HCB, Wehner N, Stamey T: Comparison of a polyclonal and monoclonal immunoassay for PSA: Need for an international antigen standard. J Urol 144:1516-1522, 1990.
7. Christensson A, Laurell CB, Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194:755-763, 1990.
8. Christensson A, Bjork T, Nilsson O, et al.: Serum prostate specific antigen complexed to a1-antichymotrypsin as an indicator of prostate cancer. J Urol 150:100-105, 1993.
9. Lilja H, Cockett ATK, Abrahamsson P-A: Prostate specific antigen predominantly forms a complex with alpha1-antichymotrypsin in blood. Cancer Supplement 70:230-234, 1992.
10. Lilja H, Christensson A, Dahlen U, et al.: Prostate-specific antigen in serum occurs predominantly in complex with α1-Antichymotrypsin. Clin Chem 37:1618-1625, 1991.
11. Stenman UH, Leinonen J, Alfthan H, et al.: A complex between prostate-specific antigen in serum and α1-Antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer Assay of the Complex Improves Clinical Sensitivity for Cancer. Can Res 51:222-226, 1991.
12. Wu JT, and Stephenson RA: Microplate assays for free PSA, PSA-ACT and total PSA: assay characteristics, selection of calibrators and in vitro stability studies. Proceeding for the 1st International Consultation on Prostate Cancer, 1997, p 159-168.
13. PSA-ACT high background paper.
14. Wu JT, Zhang P, Wang T et al: Evaluation of free PSA isoforms. PSA complex formation and specificity of anti-PSA antibodies by HPLC and PAGE-immunoblotting techniques. J Clin Lab Anal 9:1-14, 1995.
15. Wu JT, Liu GH, Zhang P: Effect of denaturation and curve fitting on the accuracy of microplate fPSA assay (submitted).